Search research articles
Contact Us
Filters
Showing results (301-310 of 519) with videos related to
Page
of 52
Sort By:
Scientific Reports
|
October 18, 2019
Cereblon gene variants and clinical outcome in multiple myeloma patients treated with lenalidomide
Phoebe A Huang, Shaunna L Beedie, Cindy H Chau, et al.
Biorxiv : the Preprint Server for Biology
|
January 30, 2023
Impact of rare structural variant events in newly diagnosed multiple myeloma
Monika Chojnacka, Benjamin Diamond, Bachisio Ziccheddu, et al.
Investigational New Drugs
|
March 4, 2020
Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma
Eric K Rowinsky, Agne Paner, Jesus G Berdeja, et al.
JAMA Oncology
|
October 27, 2022
Clinical Trial Participation Among Older Adult Medicare Fee-for-Service Beneficiaries With Cancer
Angela K Green, Sara M Tabatabai, Carol Aghajanian, et al.
British Journal of Haematology
|
May 24, 2022
Subgroup analysis based on cytogenetic risk in patients with relapsed or refractory multiple myeloma in the CANDOR study
Ola Landgren, Katja Weisel, Laura Rosinol, et al.
Leukemia
|
April 23, 2020
Phase 1 study of the anti-BCMA antibody-drug conjugate AMG 224 in patients with relapsed/refractory multiple myeloma
Hans C Lee, Noopur S Raje, Ola Landgren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 6, 2016
Impact of Genes Highly Correlated with MMSET Myeloma on the Survival of Non-MMSET Myeloma Patients
S Peter Wu, Ruth M Pfeiffer, Inhye E Ahn, et al.
European Journal of Haematology
|
February 10, 2021
Comorbidities in multiple myeloma and implications on survival: A population-based study
Ingigerður S Sverrisdóttir, Sölvi Rögnvaldsson, Sigrún Thorsteinsdottir, et al.
JCO Global Oncology
|
August 12, 2022
Global Myeloma Trial Participation and Drug Access in the Era of Novel Therapies
Raleigh Ayoolu Fatoki, Kelly Koehn, Amar Kelkar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 18, 2011
Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008
Magnus Björkholm, Lotta Ohm, Sandra Eloranta, et al.
Page
of 52
Search research articles
Search
Showing results (301-310 of 519) with videos related to
Sort By:
Page
of 52
Scientific Reports
|
October 18, 2019
Cereblon gene variants and clinical outcome in multiple myeloma patients treated with lenalidomide
Phoebe A Huang, Shaunna L Beedie, Cindy H Chau, et al.
Biorxiv : the Preprint Server for Biology
|
January 30, 2023
Impact of rare structural variant events in newly diagnosed multiple myeloma
Monika Chojnacka, Benjamin Diamond, Bachisio Ziccheddu, et al.
Investigational New Drugs
|
March 4, 2020
Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma
Eric K Rowinsky, Agne Paner, Jesus G Berdeja, et al.
JAMA Oncology
|
October 27, 2022
Clinical Trial Participation Among Older Adult Medicare Fee-for-Service Beneficiaries With Cancer
Angela K Green, Sara M Tabatabai, Carol Aghajanian, et al.
British Journal of Haematology
|
May 24, 2022
Subgroup analysis based on cytogenetic risk in patients with relapsed or refractory multiple myeloma in the CANDOR study
Ola Landgren, Katja Weisel, Laura Rosinol, et al.
Leukemia
|
April 23, 2020
Phase 1 study of the anti-BCMA antibody-drug conjugate AMG 224 in patients with relapsed/refractory multiple myeloma
Hans C Lee, Noopur S Raje, Ola Landgren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 6, 2016
Impact of Genes Highly Correlated with MMSET Myeloma on the Survival of Non-MMSET Myeloma Patients
S Peter Wu, Ruth M Pfeiffer, Inhye E Ahn, et al.
European Journal of Haematology
|
February 10, 2021
Comorbidities in multiple myeloma and implications on survival: A population-based study
Ingigerður S Sverrisdóttir, Sölvi Rögnvaldsson, Sigrún Thorsteinsdottir, et al.
JCO Global Oncology
|
August 12, 2022
Global Myeloma Trial Participation and Drug Access in the Era of Novel Therapies
Raleigh Ayoolu Fatoki, Kelly Koehn, Amar Kelkar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 18, 2011
Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008
Magnus Björkholm, Lotta Ohm, Sandra Eloranta, et al.
Page
of 52